4.3 Article

Older patients benefit more from sequential courses of washed microbiota transplantation than younger population with ulcerative colitis

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials

Nabil El Hage Chehade et al.

Summary: This study systematically reviewed the efficacy of fecal microbiota transplantation in patients with ulcerative colitis through double-blind randomized controlled trials. The results indicated that FMT can induce short-term clinical and endoscopic remission in patients with ulcerative colitis, with a comparable safety profile to placebo.

INFLAMMATORY BOWEL DISEASES (2023)

Article Gastroenterology & Hepatology

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

Tim Raine et al.

JOURNAL OF CROHNS & COLITIS (2022)

Article Gastroenterology & Hepatology

Lower effectiveness of intravenous steroid treatment for moderate-to-severe ulcerative colitis in hospitalised patients with older onset: A multicentre cohort study

Shinji Okabayashi et al.

Summary: This study aimed to evaluate the effectiveness and risks of treatment in older-onset ulcerative colitis (UC) patients. The results showed that older-onset patients had lower effectiveness with intravenous steroids and higher risks of surgery and adverse events.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Gastroenterology & Hepatology

Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial

Chen Sarbagili Shabat et al.

Summary: This study evaluated the impact of novel diets and fecal transplantation on the remission rate of refractory ulcerative colitis. The results suggest that using the UC Exclusion Diet alone may be more effective in achieving clinical remission and mucosal healing compared to single donor FT or no donor diet.

JOURNAL OF CROHNS & COLITIS (2022)

Article Multidisciplinary Sciences

Environmental factors shaping the gut microbiome in a Dutch population

R. Gacesa et al.

Summary: This study analyzed the gut microbiome of 8,208 individuals from the Netherlands and found that the microbiome is primarily shaped by the environment and cohabitation. Only about 6.6% of microbial taxa are heritable, while around 48.6% of taxa are significantly influenced by cohabitation. Additionally, the study identified numerous associations between the microbiome and health, diet, socioeconomic factors, and early-life and current exposome.

NATURE (2022)

Article Biotechnology & Applied Microbiology

Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery

Gaochen Lu et al.

Summary: This study describes the methodology development of faecal microbiota transplantation (FMT) in China from manual to washing preparation, and provides insights into donor screenings, treatment doses, adverse events and delivery decisions. The success rate of donor screening was found to be 3.1%, and the incidence rate of fever decreased significantly with washed microbiota transplantation (WMT) in ulcerative colitis patients. The study also suggests a new definition for treatment units based on enriched microbiota and proposes a promising method for delivering microbiota through colonic transendoscopic enteral tube.

MICROBIAL BIOTECHNOLOGY (2022)

Review Medicine, General & Internal

Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases

Yun Wang et al.

Summary: This review provides a comprehensive overview of the clinical applications of fecal microbiota transplantation (FMT) from 2011 to 2021. The study examines the clinical benefits, processing methodology, usage strategies, and global regulations of FMT. The findings suggest that while further controlled trials are needed, FMT shows promising potential for treating dysbiosis-related diseases in the gut or beyond.

CHINESE MEDICAL JOURNAL (2022)

Article Microbiology

Long-Term Efficacy of Low-Intensity Single Donor Fecal Microbiota Transplantation in Ulcerative Colitis and Outcome-Specific Gut Bacteria

Rongrong Ren et al.

Summary: Low-intensity single donor FMT can induce long remission in active UC, and the gut microbiota composition in UC patients at baseline may predict therapeutic response to FMT.

FRONTIERS IN MICROBIOLOGY (2021)

Article Gastroenterology & Hepatology

Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study

Jessica W. Crothers et al.

Summary: The study shows that long-term oral administration of frozen encapsulated FMT is safe and effective in treating UC, with sustained improvements in gut microbial composition. Some patients achieved clinical remission, and changes in MAIT cell cytokine production may be associated with treatment response.

BMC GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease

Michael T. Dolinger et al.

Summary: In this study, 16 pediatric IBD patients received dual therapy after failing two or more biologic therapies, with 75% achieving steroid-free remission at 6 months. There were improvements in erythrocyte sedimentation rate, C-reactive protein, and albumin levels. More research is needed to confirm the safety of dual therapy in this patient population.

INFLAMMATORY BOWEL DISEASES (2021)

Article Biotechnology & Applied Microbiology

Efficacy of faecal microbiota transplantation in Crohn's disease: a new target treatment?

Liyuan Xiang et al.

MICROBIAL BIOTECHNOLOGY (2020)

Review Gastroenterology & Hepatology

The Historical Role and Contemporary Use of Corticosteroids in Inflammatory Bowel Disease

Alexander M. Dorrington et al.

JOURNAL OF CROHNS & COLITIS (2020)

Review Microbiology

The Gut Microbiota and Unhealthy Aging: Disentangling Cause from Consequence

Erica N. DeJong et al.

CELL HOST & MICROBE (2020)

Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes

Qianqian Li et al.

Clinical and Translational Gastroenterology (2020)

Article Public, Environmental & Occupational Health

Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis

Xiao Ding et al.

DRUG SAFETY (2019)

Article Medicine, General & Internal

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial

Samuel P. Costello et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Gastroenterology & Hepatology

A novel quick transendoscopic enteral tubing in mid-gut: technique and training with video

Chuyan Long et al.

BMC GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities

Ashwin N. Ananthakrishnan et al.

INFLAMMATORY BOWEL DISEASES (2017)

Article Gastroenterology & Hepatology

Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010

Raina Shivashankar et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study

D. C. Baumgart et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Review Medicine, General & Internal

The Human Intestinal Microbiome in Health and Disease

Susan V. Lynch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Gastroenterology & Hepatology

Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota

Zhaoyuan Peng et al.

ENDOSCOPY INTERNATIONAL OPEN (2016)

Article Gastroenterology & Hepatology

Step-up fecal microbiota transplantation (FMT) strategy

Bota Cui et al.

GUT MICROBES (2016)

Article Gastroenterology & Hepatology

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

Noortje G. Rossen et al.

GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results

Bota Cui et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: inflammatory bowel disease in the elderly

J. P. Gisbert et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Gastroenterology & Hepatology

Guidance on Preparing an Investigational New Drug Application for Fecal Microbiota Transplantation Studies

Colleen R. Kelly et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Multidisciplinary Sciences

Gut microbiota composition correlates with diet and health in the elderly

Marcus J. Claesson et al.

NATURE (2012)